Sanjay Shukla - 11 Dec 2023 Form 4 Insider Report for aTYR PHARMA INC (LIFE)

Role
President and CEO, Director
Signature
/s/ Nancy E. Denyes, Attorney-in-Fact
Issuer symbol
LIFE
Transactions as of
11 Dec 2023
Net transactions value
+$17,646
Form type
4
Filing time
12 Dec 2023, 18:50:14 UTC
Previous filing
13 Nov 2023
Next filing
09 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIFE Common Stock Purchase $3,510 +3,000 +3.3% $1.17 94,173 11 Dec 2023 Direct
transaction LIFE Common Stock Purchase $14,136 +12,000 +13% $1.18 106,173 12 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.175 to $1.18 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.